Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

"You are confirming another reason (beside double-blinded) why there was not and could not be an "Interim Efficacy Analysis" in the Brilacidin-COvid-19 Clinical Trials"

So, let me get this straight:

By linking to an actual example of a brilacidin double blind study where an interim efficacy was conducted*, I'm confirming that:

" there was not and could not be an "Interim Efficacy Analysis" in the Brilacidin-COvid-19 Clinical Trials"

I'm not sure how anyone could reasonably reach that conclusion.

Perhaps you could explain further.

"Cellceutix is encouraged by the interim data from the OM trial (a double blind, placebo controlled study"

*https://www.ipharminc.com/press-release/2017/4/8/cellceutix-ceo-discusses-brilacidin-following-interim-trial-results-exceeding-expectations-for-treating-oral-mucositis-and-inflammatory-bowel-disease?rq=interim